A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET)
Clinical trial NCT02288377 · TERMINATED
Trial details
- NCT number
- NCT02288377
- Sponsor
- Federation Francophone de Cancerologie Digestive
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2020-01-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.